Advanced Pretibial Melanoma (APM): Clinicians Behaviour As Triggering Factor? by Tchernev, Georgi et al.
_______________________________________________________________________________________________________________________________ 
64                                                                                                                                                                                                  https://www.id-press.eu/mjms/index 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2018 Jan 25; 6(1):64-66. 
Special Issue: Global Dermatology-2 
https://doi.org/10.3889/oamjms.2018.003 
eISSN: 1857-9655 
Case Report 
 
 
  
 
Advanced Pretibial Melanoma (APM): Clinicians Behaviour As 
Triggering Factor? 
 
 
Georgi Tchernev
1,2*
, Ivan Pidakev
3
, Anastasiya Atanasova Chokoeva
1
, Uwe Wollina
4
, Torello Lotti
5
, Georgi Konstantinov 
Maximov
1
, Ilia Lozev
6
 
 
1
”Onkoderma”- Policlinic for Dermatology and Dermatologic Surgery, Sofia, Bulgaria; 
2
Medical Institute of Ministry of Interior 
(MVR-Sofia), Department of Dermatology, Venereology and Dermatologic Surgery, General Skobelev 26, 1606 Sofia, 
Bulgaria; 
3
Medical Institute of Ministry of Interior, Department of General, Vascular and Abdominal Surgery, General 
Skobelev 79, 1606 Sofia, Bulgaria; 
4
Department of Dermatology and Allergology, Städtisches Klinikum Dresden, Dresden, 
Germany; 
5
University of Rome G. Marconi, Rome 00186, Italy 
6
Medical Institute of Ministry of Interior, Department of 
General, Vascular and Abdominal Surgery, General Skobelev 79, 1606 Sofia, Bulgaria 
 
Citation: Tchernev G, Pidakev I, Chokoeva AA, Wollina 
U, Lotti T, Maximov GK, Lozev I. Advanced Pretibial 
Melanoma (APM): Clinicians Behaviour As Triggering 
Factor? Open Access Maced J Med Sci. 2018 Jan 25; 
6(1):64-66. https://doi.org/10.3889/oamjms.2018.003 
Keywords: melanoma; seborrheic keratosis; imitation; 
surgery; risk behaviour; outcome 
*Correspondence: Georgi Tchernev. Department of 
Dermatology, Venereology and Dermatologic Surgery, 
Medical Institute of Ministry of Interior (MVR-Sofia), 
General Skobelev 79, 1606 Sofia, Bulgaria; Onkoderma - 
Policlinic for Dermatology, Venereology and Dermatologic 
Surgery, General Skobelev 26, 1606, Sofia, Bulgaria. Tel.: 
+389 72 232 513. E-mail: georgi_tchernev@yahoo.de 
Received: 26-Jul-2017; Revised: 02-Aug-2017; 
Accepted: 21-Aug-2017; Online first: 31-Dec-2017 
Copyright: © 2018 Georgi Tchernev, Ivan Pidakev, 
Anastasiya Atanasova Chokoeva, Uwe Wollina, Torello 
Lotti, Georgi Konstantinov Maximov, Ilia Lozev. This is an 
open-access article distributed under the terms of the 
Creative Commons Attribution-NonCommercial 4.0 
International License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
Abstract  
BACKGROUND: Pigmented lesions represent a broad spectrum of clinical conditions, both benign and 
malignant. The precise diagnosis is often a challenge, while the clinical diagnostic criteria could be misleading, as 
a result of the frequently atypical presentation of otherwise completely benign in nature lesions. The variety of 
therapeutic options for benign pigmented lesions including shave curettage, local laser destruction, 
electrocoagulation removal could sound enticingly both for the physician and patient, but they destroy the 
possibility for histological examination and provide a deceptively feeling of calm, that the problem is solved. If 
there is even a minimum chance for misdiagnosis, the risk could be a human life. Furthermore, a simple surgical 
excision could provide total resolution of the problem, with correct histological verification and further therapeutic 
measurements, if needed.  
CASE REPORT: We present a case of a patient, with advanced pretibial melanoma with multiple lung 
metastases, misdiagnosed as a seborrheic keratosis, treated with shave-curettage 6 months earlier, as we want 
to emphasize the importance of the correct therapeutic method in all cases with pigmented lesions with unknown 
origin, in order to minimize the risk of dramatic consequences of misdiagnosis of melanoma. So, we want to ask 
you- is this risk justified? 
CONCLUSION: So, we want to ask you - is this risk justified?  
 
 
 
 
Introduction 
 
Pigmented lesions represent a broad 
spectrum of clinical conditions, both benign and 
malignant [1]. The precise diagnosis is often a 
challenge, while the clinical diagnostic criteria could 
be misleading, as a result of the frequently atypical 
presentation of otherwise completely benign in nature 
lesions [1]. In contrast, numerous malignant 
keratinocyte cutaneous tumours could also be 
atypically presented, especially in their pigmented 
variants, where the precise clinical diagnosis is almost 
impossible [2]. Furthermore, while the treatment 
of pigmented lesions includes several approaches, 
from local destruction to incision biopsy, and the 
clinician’s choice depends on the nature of the 
cutaneous lesion, mistakes could be quite dangerous, 
as in the presented case. The implication of 
dermoscopy in routine dermatologic practice achieve 
an improvement of the malignant/benign diagnostic 
ratio in excised lesions, leading to a more appropriate 
selection of pigmented lesions referred to surgery 
[2]. In another hand, is this risk justified, if the bet is a 
human life? 
 
 
Case report 
A 71-year-old Caucasian female patient, 
presented with a 6-months history of rapidly 
increasing in size pigmented lesion, located on the 
medium front part of her right lower leg. The lesion 
has been presented for many years, occurring as 
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small pigmented maculae, gradually increasing in 
size. Two years ago, the lesion had been removed by 
shave curettage, with the clinical observation of 
pigmented seborrheic keratosis. No, follow up had 
been recommended to the patient. A couple of months 
after the procedure, the lesion occurred again, but 
rapidly increased its size from a small coin to a palm. 
Clinical examination revealed well-demarcated, oval-
shaped, dark-brown to the black uneven coloured 
pigmented lesion, measuring approximately 15/5 cm, 
irregularly bordered, covered with yellow crusts and 
partially ulcerated surface, located on the frontal 
medium part of the right lower leg (Fig. 1a,b).  
Burning sensations and formications of the 
same leg were presented as subjective complaints. 
Arterial hypertension, controlled with medicine and 
status post thrombosis of v. popliteal dextra, with 
patch plastic autogenous, performed two years ago, 
were reported from the medical history. Family history 
was negative for cutaneous diseases. Total surgical 
excision of the lesion was performed under local 
anaesthesia; with the field of safety margins 1cm. 
Histological examination verified the diagnosis of 
melanoma, with a tumor thickness of 4 mm. 
 
 
Figure 1: a,b – a Clinical manifestation of advanced pretibial 
melanoma, 6 months after shave curettage of the so-called 
“seborrheic keratosis”; 1c – Preoperative marking of the surgical 
safety margins; 1d, e, f, g – Intraoperative findings: Elliptic surgical 
excision under local anesthesia; 1h- Postoperative findings. Closing 
of the wound with single stitches 
 
Laboratory blood tests established elevated 
level of glucose (6.5 mmol/l), direct bilirubin (4.4 
mmol/l), alcal phosphatase (185 UI/l), LDH (2381 
UI/L) and hsCRP (101.8 mg/l). The performed 
screening vie X-ray revealed multiple metastases in 
both of the lungs, with maximal diameter 40 mm. The 
diagnosis of melanoma staged IV was made. 
One metastasis was referred for BRAF 
testing, as therapy with BRAF and MEK inhibitors was 
planned, while pembrolizumab was considered in 
case of negative BRAF status.  
 
 
 
Discussion 
Although most often benign, small pigmented 
lesions remain the most significant diagnostic 
challenge, both in naked-eye and in dermatoscopic 
examinations, particularly in the diagnosis of small 
melanoma [3]. When considering the diagnosis of 
pigmented lesions, a balance between therapeutic 
aspects and cosmetic concerns have to be taken into 
account, with attention for the differential diagnosis 
between benign and malignant lesions [4]. The variety 
of therapeutic options for benign pigmented lesions 
including shave curettage, local laser destruction, 
electrocoagulation removal could sound enticingly 
both for the physician and patient, but they destroy the 
possibility for histological examination and provide a 
deceptively feeling of calm, that the problem is solved 
[2].  
Nevertheless, the recurrence rate is the 
smallest problem that should be taken into 
consideration. The most severe challenge in such 
cases is the correct differentiation between the benign 
and potentially malignant nature of the lesion that 
must be treated [4]. As it was already mentioned, the 
diagnosis is not often correct even with dermoscopy 
or confocal microscopy, although these diagnostic 
weapons could be high sensitive and precise [5][6]. 
When considering a pigmented lesion with unknown 
origin, once should always keep in mind that the 
incidence of primary cutaneous melanoma has been 
increasing dramatically for several decades, as this 
kind of tumour is responsible for the majority of skin 
cancer-related deaths. Furthermore, the most 
important diagnostic point is the early diagnosis and 
treatment with simple excision, because if the 5 year- 
survival rate for patient in stage I is 95% AND 70-90% 
for stage II, these percents decreased dramatically up 
to 15% in patients with stage IV [7]. If there is even a 
minimum chance for misdiagnosis, the risk could be a 
human life. Furthermore, a simple surgical excision 
could provide total resolution of the problem, with 
correct histological verification and further therapeutic 
measurements, if needed [7].  
We present a case of a patient, with 
advanced pretibial melanoma with multiple lung 
metastasis, misdiagnosed as a seborrheic keratosis 
and treated with shave-curettage 6 months earlier. We 
want to emphasize the importance of the correct 
therapeutic method in all cases with pigmented 
lesions with unknown origin, in order to minimize the 
risk of dramatic consequences of misdiagnosis of 
melanoma. So, we want to ask you- is this risk 
justified?  
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